Scarlet fever outbreak in Hong Kong, 2011

Journal of Microbiology, Immunology and Infection

Volumn 44, Issue 6, 2011, Pages 409-411

  Hsieh, Yu Chia ^a,b   Huang, Yhu Chering ^a,b  

^a CHANG GUNG CHILDREN S HOSPITAL   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; LINEZOLID; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; EPIDEMIC; FATALITY; HONG KONG; HUMAN; SCARLET FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PYOGENES;

ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HONG KONG; HUMANS; MALE; SCARLET FEVER; STREPTOCOCCUS PYOGENES; TAIWAN;

EID: 83155181597     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2011.07.003     Document Type: Article

References (24)

1. Espinosa de los Monteros L.E., Bustos I.M., Flores L.V., Avila-Figueroa C. Outbreak of scarlet fever caused by an erythromycin-resistant Streptococcus pyogenes emm22 genotype strain in a day-care center. Pediatr Infect Dis J 2001, 20:807-809.
2. Perea-Mejia L.M., Inzunza-Montiel A.E., Cravioto A. Molecular characterization of group A streptococcus strains isolated during a scarlet fever outbreak. J Clin Microbiol 2002, 40:278-280.
3. Yan J.J., Liu C.C., Ko W.C., Hsu S.Y., Wu H.M., Lin Y.S., et al. Molecular analysis of group A streptococcal isolates associated with scarlet fever in southern Taiwan between 1993 and 2002. J Clin Microbiol 2003, 41:4858-4861.
4. Perks E.M., Mayon-White R.T. The incidence of scarlet fever. J Hyg (Lond) 1983, 91:203-209.
5. Colman G., Tanna A., Efstratiou A., Gaworzewska E.T. The serotypes of Streptococcus pyogenes present in Britain during 1980-1990 and their association with disease. J Med Microbiol 1993, 39:165-178.
6. O'Brien K.L., Beall B., Barrett N.L., Cieslak P.R., Reingold A., Farley M.M., et al. Epidemiology of invasive group A streptococcus disease in the United States, 1995-1999. Clin Infect Dis 2002, 35:268-276.
7. Smoot J.C., Korgenski E.K., Daly J.A., Veasy L.G., Musser J.M. Molecular analysis of group A streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt Lake City, Utah. J Clin Microbiol 2002, 40:1805-1810.
8. Su Y.F., Wang S.M., Lin Y.L., Chuang W.J., Lin Y.S., Wu J.J., et al. Changing epidemiology of Streptococcus pyogenes emm types and associated invasive and noninvasive infections in Southern Taiwan. J Clin Microbiol 2009, 47:2658-2661.
9. Chen Y.Y., Huang C.T., Yao S.M., Chang Y.C., Shen P.W., Chou C.Y., et al. Molecular epidemiology of group A streptococcus causing scarlet fever in northern Taiwan, 2001-2002. Diagn Microbiol Infect Dis 2007, 58:289-295.
10. Chiou C.S., Liao T.L., Wang T.H., Chang H.L., Liao J.C., Li C.C. Epidemiology and molecular characterization of Streptococcus pyogenes recovered from scarlet fever patients in central Taiwan from 1996 to 1999. J Clin Microbiol 2004, 42:3998-4006.
11. Chiou C.S., Wang Y.W., Chen P.L., Wang W.L., Wu P.F., Wei H.L. Association of the shuffling of Streptococcus pyogenes clones and the fluctuation of scarlet fever cases between 2000 and 2006 in central Taiwan. BMC Microbiol 2009, 9:115.
12. Stevens D.L. Invasive group A streptococcus infections. Clin Infect Dis 1992, 14:2-11.
13. Hribalova V. Streptococcus pyogenes and the toxic shock syndrome. Ann Intern Med 1988, 108:772.
14. Bartter T., Dascal A., Carroll K., Curley F.J. "Toxic strep syndrome." A manifestation of group A streptococcal infection. Arch Intern Med 1988, 148:1421-1424.
15. Vucicevic Z., Tajic-Bencic I., Kruslin B., Degoricija V. Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults. J Microbiol Immunol Infect 2009, 42:276-279.
16. Aziz R.K., Kotb M. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg Infect Dis 2008, 14:1511-1517.
17. Huang Y.C., Hsueh P.R., Lin T.Y., Yan D.C., Hsia S.H. A family cluster of streptococcal toxic shock syndrome in children: clinical implication and epidemiological investigation. Pediatrics 2001, 107:1181-1183.
18. Hsueh P.R., Wu J.J., Tsai P.J., Liu J.W., Chuang Y.C., Luh K.T. Invasive group A streptococcal disease in Taiwan is not associated with the presence of streptococcal pyrogenic exotoxin genes. Clin Infect Dis 1998, 26:584-589.
19. Chiang-Ni C., Wu A.B., Liu C.C., Chen K.T., Lin Y.S., Chuang W.J., et al. Emergence of uncommon emm types of Streptococcus pyogenes among adult patients in southern Taiwan. J Microbiol Immunol Infect 2011, 44:415-420.
20. Chuang Y.Y., Huang Y.C., Lin T.Y. Toxic shock syndrome in children: epidemiology, pathogenesis, and management. Paediatr Drugs 2005, 7:11-25.
21. The Prevention of Invasive Group A Streptococcal Infections Workshop Participants Prevention of invasive group A streptococcal disease among household contacts of case patients and among postpartum and postsurgical patients: recommendations from the Centers for Disease Control and Prevention. Clin Infect Dis 2002, 35:950-959.
22. Hsueh P.R., Teng L.J., Lee C.M., Huang W.K., Wu T.L., Wan J.H., et al. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 data. Antimicrob Agents Chemother 2003, 47:2152-2157.
23. Hsueh P.R., Shyr J.M., Wu J.J. Changes in macrolide resistance among respiratory pathogens after decreased erythromycin consumption in Taiwan. Clin Microbiol Infect 2006, 12:296-298.
24. McNeil S.A., Halperin S.A., Langley J.M., Smith B., Warren A., Sharratt G.P., et al. Safety and immunogenicity of 26-valent group A streptococcus vaccine in healthy adult volunteers. Clin Infect Dis 2005, 41:1114-1122.